On behalf of Hepatology Congress 2018 Organizing Committee, we are pleased to invite Hepatologists, Gastroenterologists, Physicians, Internists, Microbiologists, Pathologists, Virologists, Oncologists, Surgeons, Toxicologists, Researchers, Students, Business delegates and Young researchers across the world to attend 8thEdition of International Conference on Hepatology which is to be held on July 09-10, 2018 at Vienna, Austria. The conference highlights the theme “To discuss and share the latest updates and cutting-edge technologies in the field of Hepatology”.
The conference proceedings include symposiums and workshops, keynote speeches, plenary talks, poster sessions and panel discussion on latest research developments in the field of Hepatology.
EuroSciCon is the longest running independent life science events company with a predominantly academic client base. Our multiprofessional and multispeciality approach creates a unique experience that cannot be found with a specialist society or commercially.
Euroscicon are corporate members of the following organisations
Royal Society of Biology
British Society for Immunology
Rare Care UK
Opportunities for Conference Attendees
For Researchers &Faculty:
For Universities, Associations & Societies:
For Students & Research Scholars:
Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
For Business Delegates:
Book Launch event
Exhibitor and Vendor booths
Marketing and Networking with clients
Hepatology is a branch of medicine concerned with the study, prevention, diagnosis and management of diseases that affect the liver, gallbladder, biliary tree and pancreas. The term hepatology is derived from the Greek words “hepatikos” and “logia,” which mean liver and study, respectively.
The main aim of this conference is to gather Hepatologists, Gastroenterologists, Pathologists, Directors/CEO & Industry experts, Professors, Researchers, Scientists and Students of Hepatology and Liver diseases in all areas of Liver diseases & Therapeutics and to provide an international forum for the dissemination of original research results, new ideas and practical development experiences related to the research.
MARKET ANALYSIS REPORT
Hepatology deals with the study, prevention, diagnosis and management of diseases that affect the liver, gallbladder, biliary tree and pancreas. The therapy of liver diseases has a growing importance as the number of patients in need is still rising .Hepatitis is an inflammatory condition of the liver caused by the hepatitis virus. The most observed form of this disease is hepatitis A, hepatitis B and hepatitis C. More than 1 million people die each year from causes related to viral hepatitis, commonly cirrhosis and liver cancer. According to WHO nearly 500 million people have chronic viral hepatitis worldwide. Approximately 1 in 12 persons worldwide are living with chronic viral hepatitis. Presently, an estimated 5.5 million Americans suffer from chronic liver disease . One of the top most leading causes of death of liver diseases is due to the combined diagnoses of chronic liver disease, cirrhosis, viral hepatitis and liver cancer.
Hepatology medicine is on the threshold of massive changes. Vaccination programs can help but still the mortality rate due to Liver diseases is increasing day by day and it is stated as a complicated one. Worldwide therapy of the consequences of viral hepatitis for the liver is available only for a minority. Access to innovative treatment of liver cancer and its therapy is limited here.